ReviewFoods (Basel, Switzerland)2026
State-of-the-Art Perspectives on Postbiotic-Oriented Systems Derived from Fermented Medicinal Plant Extracts.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Fermentation is increasingly used as a controlled bioprocessing approach to modify medicinal plant extracts by selectively transforming phytochemicals while maintaining safety and compositional integrity. Controlled in vitro fermentation has gained attention as a practical method to generate stable, cell-independent bioactivity consistent with postbiotic concepts. This review examines Scopus-indexed studies on fermented medicinal plant extracts, focusing on microbial platforms, fermentation strategies, dominant biotransformation pathways, and functional outcomes. Evidence indicates that fermentation is not a uniform process but follows platform-specific enzymatic pathways that reshape phenolics, flavonoids, alkaloids, and polysaccharides. Lactic acid bacteria (LAB) are most frequently applied due to their safety profile and enzymatic capacity, while yeasts and filamentous fungi enable complementary matrix restructuring and deeper chemical modification. Across systems, fermentation-driven biotransformation produces bioactive profiles that persist independently of microbial viability, supporting a postbiotic-oriented interpretation. Applications have been reported in food, nutraceutical, cosmetic, and animal nutrition contexts, although clinical translation remains limited. Remaining challenges include incomplete mechanistic understanding, limited standardization, and unclear regulatory positioning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.